Table 3.

Diabetes medication exposure in the other diabetes medication group during follow up.

	Other diabetes medication group (n = 15,059)
Sulfonylurea	5661 (37.6%)
Mean days supply (SD)	54.2 (109.27)
Median (interquartile range)	0.0 (0–50)
Min, max days supply	0, 930
Glucagon-like peptide-1 agonist	380 (2.5%)
Mean days supply (SD)	2.7 (24.01)
Median (interquartile range)	0.0 (0–0)
Min, max days supply	0, 540
Thiazolidinedione	2601 (17.3%)
Mean days supply (SD)	27.6 (84.21)
Median (interquartile range)	0.0 (0–0)
Min, max days supply	0, 900
Dipeptidyl peptidase-IV inhibitor	828 (5.5%)
Mean days supply (SD)	8.7 (48.88)
Median (interquartile range)	0.0 (0–0)
Min, max days supply	0, 810
Insulin	3822 (25.4%)
Mean days supply (SD)	28.3 (85.88)
Median (interquartile range)	0.0 (0–10)
Min, max days supply	0, 1049
Number of diabetes medications
2	1198 (8.0%)
3	94 (0.6%)
4	9 (0.06%)

SD, standard deviation.